Potent, selective CysLT1
) leukotriene receptor antagonist (IC50
= 6.4 nM). Inhibits LTD4
-induced bronchoconstriction in guinea pigs when administered intravenously, orally or by aerosol.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Ro 24-5913: a potent, specific, orally active LTD4 antagonist.
Pharmacologic actions of Ro 24-5913, a novel antagonist of leukotriene D4.
O'Donnell et al.